期刊文献+

胰岛素降解酶在阿尔茨海默病发病机制中的研究进展 被引量:2

The role of insulin-degrading enzyme in pathogenesis of Alzheimer's disease
原文传递
导出
摘要 阿尔茨海默病(Alzheimer’s disease,AD)是一种以进行性认知功能减退为特征的神经退行性疾病。发病的确切机制尚未完全清楚。目前认为胰岛素抵抗与胰岛素信号系统受损是加速AD发病的危险因素,胰岛素降解酶(insulin-degrading enzyme,IDE)在糖代谢异常促使AD发病的过程中发挥重要的作用。除调节β淀粉样蛋白降解和清除之外,还可能通过调节tau蛋白磷酸化水平,协同载脂蛋白Eε4(ApoEε4)及影响胰岛素信号传导等参与AD的发病机制。本文就IDE生物学特性及在AD发病机制中的作用作一综述。 Alzheimer's disease (AD) is a neurodegenerative diseases characterized by progressive cognitive function impaired. The pathogenesis of AD is still not understood. At present, it is considered that insulin resistance and imPaired insulin signaling system accelerate the risk of onset for AD. The link between abnormal glucose metabolism and AD is insulin-degrading enzyme (IDE), which plays a major role in the pathogenesis of AD. In addition to the regulation of β-amyloid clearance and degradation, IDE take part in the pathogenesis of AD also by regulating the phosphorylation of tau protein, apolipoprotein -Eε4 (ApoEε4) and the effects of insulin signaling. The biological characteristics of IDE and its role in the. pathogenesis of AD are reviewed here.
出处 《生命科学》 CSCD 北大核心 2009年第1期126-130,共5页 Chinese Bulletin of Life Sciences
关键词 胰岛素降解酶 阿尔茨海默病 Β淀粉样蛋白 TAU蛋白 载脂蛋白Eε4 胰岛素信号传导 insulin degrading enzyme Alzheimer's disease β-amyloid tau protein apolipoprotein -Eε4 insulin signaling
  • 相关文献

参考文献1

共引文献14

同被引文献15

  • 1王开富,陆付耳,徐丽君,冷三华,黄光英.胆碱酯酶抑制剂对化学性糖尿病影响的实验研究[J].中国病理生理杂志,2004,20(9):1586-1586. 被引量:13
  • 2Wang ZF Li HL Li XC Zhang Q Tian Q Wang Q Xu H Wang JZ.Effects of endogenous beta-amyloid overproduction on tau phosphorylation in cell culture.[J].中国生物学文摘,2006,20(9):5-6. 被引量:15
  • 3Ji HF, Shen L. Berberine: a potential muhipotent natural product to combat Alzheimer's disease [ J ]. Molecules, 2011, 16(8) : 6732-6740.
  • 4Armstrong RA. The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis" [ J ]. Int J Alzheimer's Dis, 2011, 2011:630865.
  • 5Butterfield DA, Swomley AM, Sultana R. Amyloid :-peptide (1-42)-induced oxidative stress in alzheimer disease: importance in disease pathogenesis and progression [ J]. Antioxidants Redox Signal, 2013, 19(8) : 823-835.
  • 6Liu YX, Guan H J, Beckett TL, et al. In vitro and in vivo degradation of Abeta peptide by peptidases coupled to eryth- rocytes [ J ]. Peptides, 2007, 28 (12) :2348-2355.
  • 7Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis [ J ]. Science, 1992, 256 (5054) : 184-185.
  • 8PSrea A, Morelli L, Cresto JC,et al. Degradation of soluble amyloid beta peptides 1-40, 1-42, and the Dutch variant 1- 40Q by insulin degrading enzyme from Alzheimer disease and control brains [ J ]. Neurochem Res, 2000, 25 (2) .. 247-255.
  • 9Zhao Z, Xiang Z, Haroutunian V, et al. Insulin degrading enzyme activity selectively decreases in the hippocampal for- mation of cases at high risk to develop Alzheimer's disease [J]. Neurobiol Aging, 2007, 28(6):824-830.
  • 10Iwatan N, Takaki Y, Fukami S,et al. Region-specific of a beta-degrading endopeptidase, neprilysin, in mouse hippo- campus upon aging [ J ]. J Neurosci Res, 2002, 70 ( 3 ) : 493-500.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部